Tak Paul Peter bought CADL
January 26, 2026 · Form 4 insider transaction
Tak Paul Peter bought 629,000 shares of Candel Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
629,000
Price
$0.00
Total value
N/A
InsiderTak Paul Peter
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 26, 2026
Filing dateJanuary 28, 2026
Shares owned after629,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date.